Related by context. All words. (Click for frequent words.) 74 ventricular tachyarrhythmias 73 arrhythmias 73 ventricular tachycardia 72 ventricular arrhythmia 71 ventricular tachycardia VT 70 ventricular fibrillation VF 69 ventricular fibrillation 68 atrial arrhythmias 68 ICD shocks 68 tachyarrhythmias 68 torsades de pointes 67 torsade de pointes 67 VT VF 67 rhythm disturbances 66 ventricular tachycardias 66 thromboembolic events 66 tachyarrhythmia 66 ventricular tachyarrhythmia 66 left ventricular dysfunction 65 hyperkalemia 65 β blockers 65 electrical cardioversion 65 thromboembolic 64 abnormal rhythms 64 thrombotic events 64 paroxysmal AF 64 Ventricular fibrillation 64 QT interval prolongation 64 postoperative AF 64 sudden cardiac death 64 repolarization 63 cerebrovascular events 63 abnormal heartbeats 63 acute decompensation 63 thromboembolism 63 Ventricular Tachycardia 63 dysrhythmias 63 prolonged QT interval 63 myocardial ischemia 63 hypoperfusion 63 hypoxemia 63 thrombotic complications 63 microvascular disease 63 reinfarction 63 hypercalcemia 63 Hypotension 63 heart arrhythmias 63 resynchronization therapy 62 postoperative atrial fibrillation 62 lethal arrhythmias 62 irregular heartbeats 62 QTc intervals 62 QT prolongation 62 cardiogenic shock 62 ischemic complications 62 sustained ventricular tachycardia 62 cerebral vasospasm 62 cardiomyopathies 62 thromboembolic complications 62 systolic dysfunction 62 decompensated heart failure 62 airway constriction 62 cerebral ischemia 62 arterial revascularization 62 reperfusion injury 62 cardiac biomarkers 62 aortic valve stenosis 61 unstable angina pectoris 61 Ventricular tachycardia 61 nonischemic 61 bradycardia 61 asystole 61 thrombus formation 61 hemodynamic instability 61 renal dysfunction 61 Arrhythmias 61 antithrombotic therapy 61 fatal arrhythmias 61 mitral stenosis 61 preserved ejection fraction 61 cardiac tamponade 61 arrhythmia 61 bypass grafting 61 neurologic symptoms 61 clot formation 61 intracerebral 61 QTc interval 61 acute aortic dissection 61 severe hypoglycemia 60 cardiac dysfunction 60 esophageal perforation 60 arrhythmogenic 60 threatening arrhythmias 60 tachycardias 60 Erythropoietic therapies may 60 vasospasm 60 intracerebral hemorrhage 60 recurrent VTE 60 hyperalgesia 60 CYP #A# 60 cardiac resynchronization 60 cardiac conduction 60 silent ischemia 60 lactic acidosis 60 arrythmias 60 PSVT 60 androgen deprivation 60 intracranial bleeding 60 Torsades de Pointes 60 postoperative complication 60 isoproterenol 60 antiarrhythmic drug 60 non valvular atrial 60 cardioembolic stroke 60 fibrinolysis 60 tachycardia 60 myocardial infarctions 60 corticosteroid therapy 60 cytopenias 60 vascular dysfunction 60 atrial fibrillation 60 cardiac troponin 60 subarachnoid hemorrhages 60 NYHA Class II 60 ischemic cardiomyopathy 60 malperfusion 60 neointimal hyperplasia 60 VAPRISOL 60 sinus node 60 T2DM 60 ischemia reperfusion 60 hyperammonemia 59 serum calcium levels 59 baroreflex 59 hemorrhagic complications 59 antiarrhythmic drugs 59 TNF antagonist 59 rhythm abnormalities 59 metabolic acidosis 59 fluid overload 59 chronic GVHD 59 QT intervals 59 hypoglycemic episodes 59 arterial calcification 59 platelet activation 59 ICD implantation 59 revascularization procedures 59 intermittent hypoxia 59 acidosis 59 QTc prolongation 59 valvular disease 59 hyperglycaemia 59 thrombi 59 microvascular complications 59 cardiac repolarization 59 sinus tachycardia 59 aminotransferases 59 atherosclerotic disease 59 ADPKD 59 intracerebral haemorrhage 59 conventional angiography 59 androgen ablation 59 arrhythmogenic right 59 thrombus aspiration 59 autoregulation 59 perioperative complications 59 infarcts 59 atrial tachyarrhythmias 59 fibrillation 59 infarctions 59 CPVT 59 ruptured aneurysms 59 intensive statin therapy 59 deferiprone 59 cerebral infarction 59 kidney dysfunction 59 long QT syndrome 59 hepatotoxicity 59 renal insufficiency 59 adrenalectomy 59 tortuosity 59 transvenous 59 periprocedural 58 polymorphic ventricular tachycardia 58 refractory ischemia 58 hemodilution 58 cardioprotection 58 intracranial hemorrhage ICH 58 HPA axis suppression 58 catecholamine 58 cardiopulmonary bypass CPB 58 cardiopulmonary bypass 58 antiplatelet medications 58 variceal bleeding 58 rebleeding 58 induce regression 58 macrovascular disease 58 MULTAQ 58 rate variability HRV 58 untreated sleep apnea 58 denervation 58 left ventricular hypertrophy 58 GISTs 58 EXJADE 58 QT interval 58 Critical limb ischemia 58 pericardial effusion 58 multivessel disease 58 endometrial carcinoma 58 neurologic complications 58 coronary artery disease 58 reoperations 58 AV node 58 flecainide 58 PSADT 58 coronary stenosis 58 cardiac abnormalities 58 artery stenosis 58 hyperprolactinemia 58 Cardiac arrhythmias 58 sotalol 58 vascular inflammation 58 antihypertensive therapy 58 cystic lesions 58 myocardial infarction MI 58 coronary occlusion 58 hydrops 58 pathologic fractures 58 electrical conduction 58 claudication 58 cardiac toxicity 58 atrioventricular block 58 arterial inflammation 58 dysrhythmia 58 Acute pancreatitis 58 allograft rejection 58 carotid stenosis 58 stent implantation 58 hyperparathyroidism 58 thyrotoxicosis 58 biventricular pacing 58 glomerular filtration 58 upper gastrointestinal bleeding 58 postoperative hemorrhage 58 noncardiovascular 58 intermittent claudication 58 subclinical hypothyroidism 58 nonvertebral fracture 58 dobutamine 58 carotid IMT 58 autonomic dysfunction 58 microalbuminuria 58 lung edema 58 functional mitral regurgitation 57 endotoxemia 57 prostate cancer CaP 57 postoperative mortality 57 Hemorrhagic strokes 57 inotropes 57 sinus node dysfunction 57 primidone 57 hypercapnia 57 troponin T 57 cardiac fibrosis 57 dopaminergic therapy 57 vasovagal syncope 57 cardiac hypertrophy 57 systemic toxicity 57 surgical debulking 57 hepatic cirrhosis 57 contractile function 57 status epilepticus 57 acute myocardial infarction AMI 57 neurologic deficits 57 corrected QT interval 57 airway narrowing 57 pacemaker implantation 57 lightheadedness fainting 57 Hurthle cell 57 aortic rupture 57 atrial fibrillation AF 57 elevated plasma concentrations 57 adrenal suppression 57 hippocampal atrophy 57 spinal metastases 57 leiomyomas 57 hypoglycaemic episodes 57 noncardiac 57 PR interval prolongation 57 rFVIIa 57 parkinsonian symptoms 57 beta blocker therapy 57 vasodilatation 57 tardive dyskinesia TD 57 hepatorenal syndrome 57 pulmonary artery banding 57 infarct size 57 left ventricular systolic 57 surgical revascularization 57 hyperoxia 57 VIIBRYD 57 coronary intervention 57 pelvic lymphadenectomy 57 diastolic function 57 nephropathy 57 invasive coronary angiography 57 SERCA2a 57 tumor lysis syndrome 57 oral anticoagulation 57 myocardial infarction 57 ejection fractions 57 fibrin deposition 57 capillary leakage 57 severe hypersensitivity reactions 57 platelet inhibition 57 inotropic 57 colorectal adenoma 57 MACCE 57 Atrial flutter 57 stable angina 57 hypertrophy 57 riociguat 57 fibrotic disease 57 curative resection 57 serum phosphate 57 cardiac resynchronisation therapy 57 coadministration 57 angina pectoris 57 prednisone prednisolone 57 antiarrhythmic 57 dronedarone 57 coronary insufficiency 57 revascularisation 57 proliferative diabetic retinopathy 57 parathyroid carcinoma 57 airflow limitation 57 prothrombotic 57 aspirin clopidogrel 57 thromboprophylaxis 57 ischaemia 57 coagulopathy 57 HPA axis 57 diastolic dysfunction 57 erratic heartbeats 57 macrovascular complications 57 pleural effusions 57 myocardial contractility 57 ventricular remodeling 57 hepatic glucose production 57 postoperative delirium 57 recurrent atrial fibrillation 57 ipsilateral stroke 57 hypotensive 57 Hemorrhagic stroke 57 intraventricular 57 vascular abnormalities 57 perioperative morbidity 57 variceal hemorrhage 57 hypersensitivity reaction 57 ablation procedures 57 intraoperative complications 57 paricalcitol 57 NATRECOR ® 57 autoimmune reactions 57 thyroid dysfunction 57 GnRH agonists 57 da mage 57 hypercalcaemia 57 ischemic 57 serum phosphate levels 57 androgen suppression therapy 57 anticlotting drugs 57 Brugada syndrome 57 recurrent ischemia 56 renal toxicity 56 myocardial fibrosis 56 Toxicities 56 beta adrenergic receptors 56 neurological complications 56 occlusive disease 56 intrathoracic 56 defibrillator CRT D 56 thrombo embolic 56 Ketoacidosis 56 pressor response 56 noncardiac surgery 56 postoperative infections 56 reblockage 56 ischemia 56 varices 56 decompensation 56 T wave alternans 56 adrenal insufficiency 56 stratifying patients 56 Sudden cardiac death 56 systolic hypertension 56 pyelonephritis 56 infarction STEMI 56 trastuzumab Herceptin ® 56 amyloid deposition 56 afterload 56 deep vein thromboses 56 hypovolemia 56 antiplatelet therapy 56 Severe hypoglycemia 56 atypical fractures 56 tumor recurrence 56 hematologic toxicity 56 pulmonary hemorrhage 56 cardiovascular hospitalization 56 venous thrombosis 56 vesicoureteral reflux 56 Surgical excision 56 electrophysiologic 56 involuntary muscle contractions 56 undergoing coronary artery 56 Lp PLA 2 56 serotonin reuptake 56 atrial pacing 56 verapamil 56 recanalization 56 Catheter ablation 56 LQTS 56 cTnT 56 nephrotoxicity 56 acute myocarditis 56 ventricular dilation 56 transaminase elevations 56 induce orthostatic hypotension 56 gastrointestinal GI motility disorders 56 acute humoral rejection 56 granulomatous 56 serum calcium 56 glucagon secretion 56 intravesical therapy 56 syncope 56 systemic hypotension 56 gallstone disease 56 amiodarone 56 recurrent DVT 56 cerebral perfusion 56 irregular quivering 56 colon perforation 56 alkalosis 56 disordered breathing 56 ximelagatran 56 retransplantation 56 rtPA 56 tracheal intubation 56 amenorrhea 56 endophthalmitis 56 vasodilatory 56 hamartomas 56 unknown etiology 56 hypoglycemia 56 microvascular dysfunction 56 atherogenesis 56 Fontan procedure 56 amenorrhoea 56 tricuspid regurgitation 56 hepatocellular 56 coronary stenoses 56 cardiac resynchronization therapy 56 bolus dose 56 GIST tumors 56 ventricular dysfunction 56 renal flares 56 Pulmonary hypertension 56 apoptotic cell 56 intracranial aneurysms 56 troponins 56 Fluid retention 56 myocardial infarct 56 fulminant hepatitis 56 angina chest 56 pancytopenia 56 cerebrovascular accidents 56 malignant neoplasm 56 airway hyperresponsiveness 56 platelet reactivity 56 coronary vessels 56 valve implantation 56 loop diuretics 56 pulmonary vasculature 56 nonvertebral fractures 56 Dronedarone 56 contrast induced nephropathy 56 metabolic abnormalities 56 myocardial reperfusion 56 nondiabetic patients 56 tension pneumothorax 56 pulmonary toxicity 56 hypoglycemic events 56 TEAEs 56 ECG abnormalities 56 prostate carcinogenesis 56 endometrial hyperplasia 56 cardiovascular 56 carcinoids 56 salmeterol HFA MDI 56 intravenous diuretics 56 hypocalcemia 56 cardioplegic arrest 56 arrhythmic 56 obstructive CAD 56 pulmonary artery hypertension 56 levodopa therapy 56 upper chambers atria 56 post thrombotic syndrome 56 gouty arthritis 56 macrovascular events 56 spinal cord compression 56 cardiac allograft vasculopathy 56 bleedings 56 coronary blockages 56 coronary revascularization 56 GnRH agonist 56 atherosclerotic lesions 56 mixed hyperlipidemia 56 peri procedural 56 supraventricular tachycardia 56 milrinone 56 cerebral vascular 56 intima media thickness 56 radiochemotherapy 56 pathophysiologic 56 intravenous bisphosphonates 56 anticoagulation 56 bacteriuria 56 postoperative morbidity 56 beta adrenergic receptor 56 transarterial 56 arterial stiffening 56 neurotrophic 56 Intussusception 56 Notch1 56 Tachycardia 56 GP IIb IIIa inhibitors 56 plasminogen activators 56 anticoagulants blood thinners 55 pericardial effusions 55 myocardial infarction stroke 55 nephrotoxic 55 primary aldosteronism 55 statins cholesterol lowering 55 pheochromocytoma 55 glycated hemoglobin levels 55 vasodilators 55 beta agonists 55 CaM kinase II 55 desmin 55 mitochondrial respiration 55 fainting lightheadedness 55 pulmonary dysfunction 55 cytoreductive surgery 55 atrioventricular 55 ventricular pacing 55 revascularization procedure 55 mTOR inhibitors 55 Sudden Cardiac Death 55 induced ischemia 55 angioplasty stenting 55 onset atrial fibrillation 55 cardiotoxicity 55 immune reconstitution 55 symptomatic pulmonary embolism 55 transurethral resection 55 pulseless electrical activity 55 heparin induced thrombocytopenia 55 disc degeneration 55 revascularization 55 Eisenmenger syndrome 55 atherothrombotic 55 renal cysts 55 Radiofrequency ablation 55 nocturnal hypoglycaemia 55 hypertrophic scars 55 LVSD 55 haematopoietic 55 ABCB1 55 transthoracic 55 tamponade 55 Implantable cardioverter defibrillators 55 excitotoxic 55 aneurysmal subarachnoid hemorrhage 55 hypervascular tumors 55 variant angina 55 lupus nephritis 55 thiazide diuretic 55 extrapyramidal symptoms 55 thromboses 55 atherothrombosis 55 serum urate levels 55 de ath 55 carotid artery blockage 55 jugular venous 55 dysfunction LVSD 55 Postoperative complications 55 lowering blood glucose 55 atherothrombotic events 55 angioedema 55 sinus bradycardia 55 aldosterone hormone 55 Rheos Therapy 55 infective endocarditis 55 diastolic heart 55 cardiac troponin T 55 coronary lesions 55 asymptomatic carotid stenosis 55 severe hypoglycemic 55 paclitaxel eluting stents 55 ischemia reperfusion injury 55 LV hypertrophy 55 recurrent myocardial infarction 55 revascularizations 55 beta adrenergic 55 fatal anaphylactic 55 antimicrobial prophylaxis 55 CTEPH 55 CK MB 55 stenoses 55 neovascularisation 55 Recurrences 55 cardiac insufficiency 55 plasma lipids 55 gallstone formation 55 unstable angina UA 55 postoperative pulmonary 55 EIPH 55 defibrillator implant 55 glucocorticoid therapy 55 Oral mucositis 55 impaired hepatic 55 advanced adenomas 55 antiplatelet agents 55 monophasic 55 distal embolization 55 impaired cognition 55 bladder contractions 55 hypomagnesemia 55 intravenous cyclophosphamide 55 serum triglyceride levels 55 IL 1ß 55 fibrinolytic 55 coronary atherosclerosis 55 distant metastases 55 undergoing CABG 55 acute phosphate nephropathy 55 syndrome OSAS 55 parathyroid gland 55 nocturnal hypoglycemia 55 dyslipidemias 55 Vitamin B# deficiency 55 QRS duration 55 cardiovascular hospitalizations 55 antithrombotic therapies 55 arterial thromboembolic events 55 reperfusion therapy 55 osteoid 55 Epileptic seizures 55 bone marrow suppression 55 Ischemia 55 hsCRP levels 55 transcatheter closure 55 intimal hyperplasia 55 subclinical hyperthyroidism 55 angiographically 55 syncopal episode 55 choroidal neovascularization 55 symptomatic paroxysmal AF 55 vasoactive 55 MGUS 55 atherogenic dyslipidemia 55 microangiopathy 55 enzymatic degradation 55 secondary hyperparathyroidism 55 nerve degeneration 55 convulsive seizures 55 nonmelanoma skin cancers 55 VEGF inhibitors 55 syncope fainting 55 paragangliomas 55 fatty acid oxidation 55 heterotopic ossification 55 chemoradiotherapy 55 antiangiogenic therapy 55 Venous thromboembolism 55 aortic dissections 55 bowel resection 55 perioperative mortality 55 hepatic steatosis 55 pulmonary emboli 55 residual platelet reactivity 55 anthracyclines 55 ketoacidosis 55 detrusor overactivity 55 severe renal impairment 55 malignant transformation 55 thrombotic 55 venous thromboembolic disease 55 metabolic disturbances 55 Unstable angina 55 rhythms arrhythmias 55 lipid lowering therapy 55 hyperacute 55 thrombophilia 55 osteosarcomas 55 narrowings 55 anaphylactoid reactions 55 restenosis 55 tHcy 55 myopathy 55 paroxysmal supraventricular tachycardia 55 nonsense mutation 55 vasoconstriction 55 intracoronary 55 CRT Ds 55 LAGB 55 systemic corticosteroids 55 bone resorption 55 Genous stent 55 thoracoscopic lobectomy 55 atrial tachycardia 55 urolithiasis 55 subtrochanteric 55 reflux symptoms 55 unruptured aneurysm 55 B7 H3 55 WBPA 55 coronary angiography 55 malignant hyperthermia 55 Thrombocytopenia 55 infarction NSTEMI 55 peripheral vasculature 55 ST elevation myocardial 55 ouabain 55 left ventricular LV 54 natriuresis 54 allergic inflammation 54 HNSCC 54 DAPT 54 PLX STROKE targeting 54 Ivabradine 54 colorectal liver metastases 54 imatinib therapy 54 coronary disease 54 diabetic ketoacidosis DKA 54 coagulation parameters 54 Anaphylactic reactions 54 elevated triglyceride levels 54 thromboembolic disease 54 mitral regurgitation MR 54 GRNCM1 54 Chronic pancreatitis 54 aortic stenosis 54 hemodynamically unstable 54 necrotizing pancreatitis 54 bowel perforations 54 femoral fracture 54 Lupus nephritis 54 perioperatively 54 neuronal dysfunction 54 sudden cardiac 54 arrythmia 54 LV dysfunction 54 threatening ventricular arrhythmias 54 natriuretic peptides 54 cardiac arrhythmia abnormal 54 leukotriene pathway 54 anti arrhythmic drugs 54 nonfatal myocardial infarction MI 54 immunosuppressive medications 54 CABG surgery 54 pulmonary exacerbations 54 myocardial 54 dephosphorylation 54 dentinal hypersensitivity 54 cardiac arrhythmia 54 sonographic appearance 54 GRK2 54 abnormal uterine bleeding 54 acute hepatic 54 acute GvHD 54 TZDs 54 pathologic fracture 54 dissolving blood clots 54 monoamine oxidase inhibitors 54 lung fibrosis 54 nephrogenic fibrosing dermopathy 54 Aortic stenosis 54 hypoventilation 54 dyssynchrony 54 pseudoaneurysms 54 lumbar disk herniation 54 liver metastasis 54 interstitial pneumonia 54 Abdominal aortic aneurysms 54 Atrial 54 NAFLD 54 serum creatinine levels 54 motor neuron degeneration 54 arteriolar 54 NF kappaB activation 54 atypical femur fractures 54 dopamine antagonists 54 nitric oxide synthase 54 overt nephropathy 54 gastric cardia 54 surgical decompression 54 intracardiac 54 osteoblastic 54 RSV infections 54 catheter angiography 54 clinically meaningful reductions 54 valvular heart disease 54 hyperinsulinemia 54 nonfatal MI 54 venous reflux 54 CrCl 54 hypotension 54 neurologic outcomes 54 arterial blockage 54 paroxysmal atrial fibrillation 54 Atrial fibrillation AF 54 prognostic significance 54 squamous cell lung cancer 54 Ischemic 54 coronary interventions 54 allodynia 54 symptomatic VTE 54 sickling 54 antiarrhythmic medications 54 SCN5A 54 bullous pemphigoid 54 insulin resistance syndrome 54 NYHA class 54 renal fibrosis 54 INVEGA ® 54 vertebral fracture 54 vasogenic edema 54 cardiovascular ischemic 54 aortic regurgitation 54 acetabular dysplasia 54 Brugada Syndrome 54 oxidized phospholipids 54 stenting procedures 54 patients undergoing CABG 54 PAOD 54 fractional shortening 54 fulminant 54 arterial fibrillation 54 vascular reactivity 54 renal artery stenosis 54 Stent thrombosis 54 brain lesions 54 abdominal adiposity 54 Hyperthyroidism 54 CLA supplementation 54 uncontrolled bleeding 54 hypothalamic amenorrhea 54 myopathy rhabdomyolysis 54 thoracic aortic aneurysm 54 androgen deficiency 54 Pulmonary Embolism PE 54 Overactive bladder 54 Atrial fibrillation 54 lipid lowering drugs 54 neurologic sequelae 54 neurological abnormalities 54 pentoxifylline 54 perfusion defects 54 aortic root replacement 54 pyridostigmine 54 vWF 54 hepatic dysfunction 54 hypokalemia hypomagnesemia 54 metaplasia 54 IL6 54 biventricular 54 heterozygous FH 54 intracranial haemorrhage 54 pseudoaneurysm 54 cardiac myocytes 54 hyperactivation 54 adrenocortical cancer 54 hepatic toxicity 54 radioiodine therapy 54 biphasic 54 HER2 overexpression 54 hyperpyrexia 54 metformin accumulation 54 mitral insufficiency 54 osteoclast activity 54 thrombogenic 54 OPCAB 54 delayed CINV 54 atrophic gastritis 54 acute coronary syndromes 54 Lemierre syndrome 54 erythropoietic 54 thrombosis 54 lipid lowering therapies 54 hematopoietic cancers 54 euvolemic hyponatremia 54 heavy menstrual bleeding 54 tranylcypromine 54 cardiovascular disease hypertension 54 parathyroid 54 hormone aldosterone 54 nonhealing wounds 54 atherothrombotic disease 54 thoracic aortic disease 54 myocardial infarction ventricular fibrillation 54 chronic thromboembolic pulmonary 54 remyelination 54 bacterial prostatitis 54 neuromuscular blockade 54 Cardiac arrhythmia 54 cinacalcet 54 carcinoid tumor 54 aldosterone antagonists 54 electrolyte imbalances 54 papillary thyroid carcinoma 54 severe exacerbations 54 cardiac 54 paraganglioma 54 anticoagulant therapy 54 infarction 54 Ileus 54 depolarization 54 GBM tumors 54 Hypertrophic cardiomyopathy 54 recurrent miscarriage 54 platelet aggregation 54 neurocognitive deficits 54 kidney insufficiency 54 idraparinux 54 Vasopressin 54 PRADAXA 54 cardioverter defibrillator 54 primary hyperparathyroidism 54 laryngospasm 54 postoperative bleeding 54 subarachnoid haemorrhage 54 prolongs survival 54 neural degeneration 54 carotid plaques 54 metabolic dysfunction 54 dermopathy 54 nonadherence 54 ocular adverse 54 myopathies 54 cardiac arrythmia 54 coronary catheterization 54 otamixaban 54 delayed gastric emptying 54 antiplatelet agent 54 underwent coronary angiography 54 MDCT angiography 54 Cardiopulmonary bypass 54 salpingo oophorectomy 54 elective PCI 54 valve regurgitation 54 thrombocytosis 54 dissolve clots 54 hepatic enzymes 54 failure NYHA 54 osteoid osteoma 54 postsurgical 54 PRADAXA #mg 54 motor neuropathy 54 LHRH agonists 54 lipomas 54 SHPT 54 hyperplastic polyps 54 urinary leakage 54 antiplatelet therapies 54 nonvascular 54 kainate 54 H. pylori eradication 54 myocyte 54 diabetic nephropathy 54 polyomavirus nephropathy 54 hypercholesterolemic patients 54 isolated systolic hypertension 54 hepatic failure 54 diabetic kidney 54 ventricular myocardium 54 HIV HCV coinfected 54 dexrazoxane 54 artery occlusion 54 microvascular angina 54 seizures comas 54 rapid heartbeats 54 paroxetine Paxil 54 untreated OSA 54 proliferative retinopathy 54 antiepileptic medications 54 femoral neck fracture